Bath & Body Works, Inc. $BBWI Stock Holdings Lessened by Bridger Management LLC

Bridger Management LLC lowered its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 13.3% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 300,619 shares of the company’s stock after selling 45,996 shares during the quarter. Bath & Body Works accounts for about 5.3% of Bridger Management LLC’s portfolio, making the stock its 6th biggest holding. Bridger Management LLC owned 0.14% of Bath & Body Works worth $9,007,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. increased its stake in shares of Bath & Body Works by 7.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock worth $334,029,000 after purchasing an additional 781,681 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in Bath & Body Works by 4.7% in the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company’s stock worth $164,397,000 after buying an additional 243,611 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Bath & Body Works by 267.8% in the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock worth $121,073,000 after buying an additional 2,907,506 shares during the last quarter. GMT Capital Corp increased its stake in Bath & Body Works by 7.3% during the 1st quarter. GMT Capital Corp now owns 3,737,700 shares of the company’s stock worth $113,327,000 after buying an additional 255,600 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. raised its holdings in shares of Bath & Body Works by 115.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after acquiring an additional 1,973,679 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Trading Down 2.3%

Shares of BBWI opened at $21.51 on Tuesday. Bath & Body Works, Inc. has a 12-month low of $21.36 and a 12-month high of $41.87. The firm has a market capitalization of $4.43 billion, a P/E ratio of 6.38, a P/E/G ratio of 0.86 and a beta of 1.53. The firm has a 50-day moving average price of $25.36 and a 200 day moving average price of $28.46.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the previous year, the firm earned $0.37 earnings per share. Bath & Body Works’s quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Friday, November 21st will be issued a $0.20 dividend. The ex-dividend date is Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a yield of 3.7%. Bath & Body Works’s dividend payout ratio is currently 23.74%.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Jefferies Financial Group dropped their price target on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a research report on Monday, October 13th. Citigroup dropped their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a report on Tuesday, August 19th. Wall Street Zen cut shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. UBS Group lowered their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research report on Friday, August 29th. Finally, Telsey Advisory Group reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Bath & Body Works in a research note on Thursday, November 13th. Ten investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $38.18.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.